Methotrexate treatment hampers induction of vaccine-specific CD4 T cell responses in patients with IMID
Objectives Methotrexate (MTX) is one of the most commonly used medications to treat rheumatoid arthritis (RA). However, the effect of MTX treatment on cellular immune responses remains incompletely understood. This raises concerns about the vulnerability of these patients to emerging infections and...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Publishing Group
2024-10-01
|
| Seri Bilgileri: | RMD Open |
| Online Erişim: | https://rmdopen.bmj.com/content/10/4/e004664.full |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
